December 30, 2025 02:46 am (IST)

Make this your homepage

Health

Supreme Court puts Aravalli redefinition on hold amid uproar, awaits new expert committee | Supreme Court strikes! Kuldeep Sengar’s bail in Unnao case suspended amid public outcry | From bitter split to big reunion! Pawars join hands again for high-stakes civic battle | CBI moves Supreme Court challenging Kuldeep Sengar's relief in Unnao rape case | Music under attack: Islamist mob attacks James concert with bricks, stones in Bangladesh, dozens hurt | Christmas vandalism sparks mass arrests in Raipur; Assam acts too with crackdown on 'religious intolerance' | BJP's VV Rajesh becomes Thiruvananthapuram Mayor after party topples Left's 45-year-rule in city corporation | ‘I can’t bear the pain’: Indian-origin father of three dies after 8-hour hospital wait in Canada hospital | Janhvi Kapoor, Kajal Aggarwal, Jaya Prada slam brutal lynching in Bangladesh, call out ‘selective outrage’ | Tarique Rahman returns to Bangladesh after 17 years

Cervical Cancer Vax

Image Credit: Wallpaper Cave

India's first indigenously developed cervical cancer vaccine launched

India Blooms News Service | @indiablooms | Sep 02, 2022, at 06:47 am

#SerumInstitute #HPV #CervicalCancer #CervicalCancerVaccine

The Serum Institute of India (SII) and the Department of Biotechnology (DBT) Thursday officially announced India's first indigenous vaccine for cervical cancer.

Union Minister of Science and Technology Jitendra Singh along with SII CEO Adar Poonawalla launched the vaccine at IIC Delhi.

Historic milestone in Preventive Healthcare,under leadership of PM Sh @NarendraModi.
India’s first indigenously developed Quadrivalent Human Papillomavirus vaccine (qHPV) against Cervical Cancer launched by Department of Biotechnology under Union Ministry of Science & Technology pic.twitter.com/EItvwgVX9J
— Dr Jitendra Singh (@DrJitendraSingh) September 1, 2022

Drugs Controller General of India (DCGI) granted market authorisation for the jibe in July.

For the first time there will be an Indian HPV vaccine to treat cervical cancer in women that is both affordable and accessible. We look forward to launching it later this year and we thank the #DCGI @MoHFW_INDIA for granting approval today.
— Adar Poonawalla (@adarpoonawalla) July 12, 2022

As many as 42 lakh women have died due to this disease in India since 2019, according to World Health Organisation (WHO) data. It is the second most frequent cancer among women in the age group between 15 to 44.

The HPV vaccine protects against the types of HPV that most often cause cervical, vaginal, and vulvar cancers.

The vaccine may be priced between Rs 200-400 but it's not finalised yet, SII CEO, Adar Poonawalla said. The company plans to manufacture 200 million doses in 2 years.

The government may launch the vaccine under the National Immunisation programme for 9-14-year-old girls in the next few months.

An indigenous, affordable Vaccine against Cervical Cancer marks an important breakthrough for Department of Biotechnology under Union Ministry of Science & Technology, taking India a step closer to PM Sh @narendraModi’s vision of preventive healthcare in #AtmanirbharBharat. pic.twitter.com/92wiGY7EEL
— Dr Jitendra Singh (@DrJitendraSingh) September 1, 2022

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.